[Meso- and rac-1,2-bis(4-fluorophenyl)ethylenediamine]chloro[sulfinylbis(methane)-S]platinum(II) chloride new water soluble platinum complexes with high anti-breast cancer activities
-
Add time:08/20/2019 Source:sciencedirect.com
The synthesis, the physiochemical and the breast cancer inhibiting properties of [meso- and rac-1,2-bis(4-fluorophenyl)ethylenediamine]chloro[sulfinylbis(methane)-S]platinum(II) chlorides (meso- and rac-4F-PtCl(DMSO)) are described. Rac-4F-PtCl(DMSO) surpasses the standard carboplatin in its effect on the human MCF-7 breast cancer cell line and is more resistant than its dichloroplatinum(II) analogue rac-4F-PtCl2 against attack of nucleophiles, a prerequisite for sufficient stability in physiological environments and consequently for marked antitumor activity in vivo.Download full-size image
We also recommend Trading Suppliers and Manufacturers of dichloro(1,2-bis(2-hydroxyphenyl)ethylenediamine)platinum II (cas 138230-33-8). Pls Click Website Link as below: cas 138230-33-8 suppliers
Prev:Synthesis and evaluation of the anti-mammary tumor activity and of the estrogenic side effects of [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes
Next:An efficient synthesis of γ-hydroxy-α,β-unsaturated aldehydic esters of 2-lysophosphatidylcholine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and evaluation of the anti-mammary tumor activity and of the estrogenic side effects of [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes08/19/2019
- Original paperTumor inhibiting [1,2-bis(fluorophenylethylenediamine]platinum-(II) complexes. Part I: synthesisSynthèse des diastéréoisomères 1,2-bis(2-,3- et 4-fluorophényl)éthylènediamines 4–6, 10–12 à partir de méso 1,2-bis(2-hydroxyphényl)éthylènediamine et de 2-,3- et 4-fluorobenzaldéhyde par la transposition de diaza-Cope et leur transformation en complexes [1,2-bis(2-,3- et 4-fluorophényl)éthylènediamine]dihaloplatine (II) (Hal = Cl: 13–18; Hal = I: 19–24) à l'aide de K2PtHaI408/18/2019


